Yilmaz et al. reported that ANGPTL3 concentrations were significantly higher in patients with nonalcoholic steatohepatitis (NASH) and positively associated with HOMA-IR [31]. Here, ANGPTL3 is linked to metabolic dysfunction-associated steatohepatitis.